Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Join | Sign in

  News Archive

Regulatory Submission for Phase 2b Trial for Novel AML Consolidation Treatment
Tuesday, March 03, 2015
BL-8040 Phase 2b study, as consolidation treatment for AML patients responding to standard induction treatment, is expected to commence shortly after receipt of regulatory approval, anticipated in next few months.

Alizé Pharma Launches Phase II Clinical Trial of AZP-531 in Prader-Willi Syndrome
Tuesday, March 03, 2015
Results are expected to be available by mid-2016.

Liberia-U.S. Clinical Research Partnership Opens Trial to Test Ebola Treatments
Saturday, February 28, 2015
Initial study will evaluate experimental drug cocktail ZMapp.

TxCell to Present at ROTH Capital Partners Investor Conference in US
Friday, February 27, 2015
TxCell invited to speak at largest US meeting for investors in emerging growth companies.

CMXC Announces Results of Preliminary Analysis of Metabolomic Assays
Friday, February 27, 2015
Analysis of metabolomic assays taken during the Phase 1 pilot clinical trial.

Ipsen Enters Into Option Agreement to Acquire Canbex Therapeutics
Friday, February 27, 2015
Canbex lead candidate for treating spasticity multiple sclerosis has successfully completed Phase I.

Shire Acquires Meritage Pharma
Thursday, February 26, 2015
Transaction adds Phase 3-ready rare GI disease product to strong pipeline.

Bristol-Myers Squibb to Expand its Immuno-Oncology Pipeline
Thursday, February 26, 2015
Gains full rights to Flexus’ lead preclinical IDO1 inhibitor F001287 and the company’s broad IDO/TDO discovery program.

Baxter Announces Baxalta as the Name of the New Global Biopharmaceutical Company
Thursday, February 26, 2015
Separation into two publicly traded companies remains on track for mid-2015.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 3443

SELECTBIO Market Reports
Go to LabTube
Go to eposters